Loading company…
Nectar Life Sciences offers allergy testing and treatment through a virtual and in-person care platform.
Founded in 2021 and based in New York, US, Nectar Life Sciences provides allergy testing and care through virtual and physical clinics, a compounding pharmacy, a lab, and a network of allergists. It tests for allergens including pollen, pets, mold, and dust mites, and offers custom-formulated under-the-tongue drops. In November 2022, it raised USD 24.25 million in Series A funding from Harmony Partners, including Juxtapose and Obvious Ventures. Co-founders include Kenneth Chahine, Ben Oyler, and Hersh Patel.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in